| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/05/2012 | US20120003308 Pharmaceutical Composition Comprising Aliskiren |
| 01/05/2012 | US20120003303 Oral enteric antidepressant formulation |
| 01/05/2012 | US20120003302 Pharmaceutical composition containing a fermented, dehydrated material with amorphous crystalline structure |
| 01/05/2012 | US20120003291 Nanobead releasing medical devices |
| 01/05/2012 | US20120003282 Pharmaceutical compositions of dextran polymer derivatives |
| 01/05/2012 | US20120003270 6-substituted isoflavonoid compounds and uses thereof |
| 01/05/2012 | US20120003261 Digoxin-like fungal glycoside with cytotoxic properties: novel assay and applications |
| 01/05/2012 | US20120003252 Isoforms of human somatostatin receptor type 5 produced by alternative processing and oligo-nucleotide pairs for detection thereof by pcr |
| 01/05/2012 | US20120003235 Anti-lymphotoxin antibodies |
| 01/05/2012 | US20120003230 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| 01/05/2012 | US20120003229 Modulators of cytokine mediated signalling pathways and integrin alphavbeta3 receptor antagonists for combination therapy |
| 01/05/2012 | US20120003227 Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders |
| 01/05/2012 | US20120003224 ANGIOGENIC AND IMMUNOLOGIC APPLICATIONS OF ANTI-CD160 SPECIFIC COMPOUNDS OBTAINABLE FROM mAb CL1-R2 |
| 01/05/2012 | US20120003222 Fzd8 extracellular domains and fzd8 extracellular domain fusion molecules and treatments using same |
| 01/05/2012 | US20120003180 Perlecan domain v protects, repairs and restores ischemic brain stroke injury and motor function |
| 01/05/2012 | US20120003153 Novel indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use |
| 01/05/2012 | US20120000806 Methods for reducing the risk of an adverse dronedarone / beta-blockers interaction in a patient suffering from atrial fibrilation |
| 01/05/2012 | DE102010030688A1 Substituierte Dicyanopyridine und ihre Verwendung Substituted dicyanopyridines and their use |
| 01/05/2012 | CA2807303A1 Inhibition of inflammation by simultaneous blockade of multiple prostanoid receptors |
| 01/05/2012 | CA2804154A1 Perlecan domain v protects, repairs and restores ischemic brain stroke injury and motor function |
| 01/05/2012 | CA2803983A1 Functional vascularization with biocompatible polysaccharide-based hydrogels |
| 01/05/2012 | CA2803971A1 Substituted dicyanopyridines and use thereof |
| 01/05/2012 | CA2803660A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 01/05/2012 | CA2803558A1 .omega.3 fatty acid compound preparation |
| 01/05/2012 | CA2803031A1 A reconstituted high density lipoprotein formulation and production method thereof |
| 01/05/2012 | CA2802891A1 Use of a2b adenosine receptor antagonists for treating pulmonary hypertension |
| 01/05/2012 | CA2802743A1 Apoptosis signal-regulating kinase inhibitors |
| 01/05/2012 | CA2802288A1 Fused heterocyclic compounds as ion channel modulators |
| 01/05/2012 | CA2801099A1 Use of a chinese medicine composition in preparing medicaments for treating secondary prevention of myocardial infarction |
| 01/04/2012 | EP2402372A2 Therapeutic agent |
| 01/04/2012 | EP2402349A1 Tricyclic pyrazolopyrimidine derivative |
| 01/04/2012 | EP2402341A2 Purinyl derivatives and their use as potassium channel modulators |
| 01/04/2012 | EP2402333A1 1,4-benzothiazepine-1-oxide derivative and pharmaceutical composition utilizing the same |
| 01/04/2012 | EP2402326A1 Crystals of hydrochloride salts of a Phenylalanine Derivative, Production Method Thereof and Use Thereof as alpha4 integrin Inhibitors |
| 01/04/2012 | EP2402310A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402309A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402020A1 Pharmaceutical composition comprising extracts of Bupleurum with immunomodulating function |
| 01/04/2012 | EP2402007A1 Coenzyme q10-containing composition for oral ingestion |
| 01/04/2012 | EP2402002A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 01/04/2012 | EP2401266A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them |
| 01/04/2012 | EP2401262A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 01/04/2012 | EP2401261A1 N-phenylacetamide derivatives, which inhibit the enzyme soat-1 and pharmaceutical and cosmetic compositions containing them |
| 01/04/2012 | EP2400972A2 Composition and methods for clotting blood |
| 01/04/2012 | EP1951254B1 [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto |
| 01/04/2012 | CN1896108B Preparation of specific anticoagulation matter and its use |
| 01/04/2012 | CN1891242B Production process for removing polycyclic aromatic hydrocarbons from ginkgo leaf extract |
| 01/04/2012 | CN1819777B Gnetum extract |
| 01/04/2012 | CN1558765B Enantiomerically pure opioid diarylmethylpiperzine and methods of using same |
| 01/04/2012 | CN102307896A Fibronectin type III domain based scaffold compositions, methods and uses |
| 01/04/2012 | CN102307871A Isoindolinone and related analogs as sirtuin modulators |
| 01/04/2012 | CN102307861A Phenylimidazole compounds |
| 01/04/2012 | CN102307585A Dipeptide having antiatherosclerotic action |
| 01/04/2012 | CN102304169A Antihypertensive polypeptide and use thereof |
| 01/04/2012 | CN102304166A Tanshinone derivative and pharmaceutical composition thereof as well as application of tanshinone derivative in pharmacy |
| 01/04/2012 | CN102304160A Preparation method and application of luteolin-7-O-gentibioside |
| 01/04/2012 | CN102304124A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 01/04/2012 | CN102304096A CETP inhibitors |
| 01/04/2012 | CN102302765A Herba sarcandrae, rhizoma cibotii, suberect spatholobus stem and muskroot-like semiaquilegia root powder for treating lower extremity varicose veins |
| 01/04/2012 | CN102302761A Preparation method of traditional Chinese medicine used for treating cardiopalmus caused by devitalization of heart yang |
| 01/04/2012 | CN102302754A Foot bath hypotensor |
| 01/04/2012 | CN102302749A Traditional Chinese medicine composition for treating renal failure caused by hypertension |
| 01/04/2012 | CN102302741A Method for preparing traditional Chinese medicine (TCM) for treating heart blood stagnation type chest stuffiness |
| 01/04/2012 | CN102302740A Preparation method of traditional Chinese medicine used for treating thoracic obstructions caused by yin deficiency of heart and kidney |
| 01/04/2012 | CN102302739A Preparation method for traditional Chinese drug for treating yin-cold stagnation type chest stuffiness |
| 01/04/2012 | CN102302697A Method for preparing traditional Chinese medicine (TCM) for treating water pathogen insulting heart type palpitation |
| 01/04/2012 | CN102302696A Method for preparing traditional Chinese medicine (TCM) for treating qi-yin deficiency chest stuffiness |
| 01/04/2012 | CN102302695A Preparation method of traditional Chinese medicine for treating phlegm turbidity and obstruction chest discomfort |
| 01/04/2012 | CN102302694A Preparation method of traditional Chinese medicine for treating timidity palpitation due to heart deficiency |
| 01/04/2012 | CN102302684A Radix notoginseng tablets for promoting blood circulation |
| 01/04/2012 | CN102302681A Medicinal composition for treating cerebral infarction |
| 01/04/2012 | CN102302645A Oral liquid for treating hypertensive cardio-cerebrovascular syndrome |
| 01/04/2012 | CN102302635A Traditional Chinese medicine for treating haemorrhoids, chilblain and pressure sore and preparation method thereof |
| 01/04/2012 | CN102302629A Channel warming and collateral dredging medicine wine |
| 01/04/2012 | CN102302611A Life-prolonging and health-preserving wine |
| 01/04/2012 | CN102302592A Preparation technology and purpose of citrus grandis peel flavones |
| 01/04/2012 | CN102302588A Chinese medicinal composition for treating palpitation caused by stagnation of heart blood |
| 01/04/2012 | CN102302566A Dampness-eliminating and stasis-removing capsules |
| 01/04/2012 | CN102302556A Extraction method of total flavonoid from coriaria sinica maxim |
| 01/04/2012 | CN102302554A Extraction method of schisandra total lignans |
| 01/04/2012 | CN102302553A Extraction method of key components of Chinese magnoliavine fruit medicament |
| 01/04/2012 | CN102302552A Capsules for treating arrhythmia and preparation method thereof |
| 01/04/2012 | CN102302550A Medicament for treating coronary heart disease |
| 01/04/2012 | CN102302549A Drug composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 01/04/2012 | CN102302548A Preparation method for compound salvia tablets |
| 01/04/2012 | CN102302539A Method for producing trifolium pratense L. isoflavones |
| 01/04/2012 | CN102302530A Medicinal liquor and preparation method thereof |
| 01/04/2012 | CN102302529A Purple ginseng prepared by vaccinium fermentation method and application thereof in medicine |
| 01/04/2012 | CN102302525A Gingko leaf composition and preparation method thereof |
| 01/04/2012 | CN102302522A Method for purifying ginkgo flavones through membrane separation |
| 01/04/2012 | CN102302513A Pig blood deproteinized extract enteric-soluble capsule and preparation process thereof |
| 01/04/2012 | CN102302510A Medicinal composition and application thereof |
| 01/04/2012 | CN102302507A Medicinal composition for directional controlled release of trace elements and preparation method and application |
| 01/04/2012 | CN102302501A Nitrate esters of corticoid compounds useful as diuretics |
| 01/04/2012 | CN102302494A Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 01/04/2012 | CN102302491A Application of sorafenib to treatment of cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH) |
| 01/04/2012 | CN102302479A Application of lycopene in preparation of medicament for treating cerebral ischemia injury |
| 01/04/2012 | CN102302470A Nitrendipine soft capsule |
| 01/04/2012 | CN102302469A Preparation method of felodipine two-layer osmotic pump controlled release tablet |
| 01/04/2012 | CN102302465A Tablet containing clopidogrel hydrogen sulfate and preparation method thereof |
| 01/04/2012 | CN102302444A Genistein injection and preparation method thereof |